Digital Musculoskeletale Care Company Hinge Health, was made public today at the NYSE under the HNGE symbol and raised around $ 437.3 million with his first public offer, which sold 9.14 million shares.
The company established in San Francisco, founded in 2014, offers patients with musculoskeletal disorders access to health coaches, orthopedic surgeons, physiotherapists and technological sources, such as the support of surgery.
Hinge also offers its portable by the FDA Enso, which offers electric pulses to relieve daily pain and a health program for pelvis women.
The company, one of the most prominent players in the Digital Musculoskeletal Care space, is open on the NYSE against a share price from $ 39.25 per share, which was 23% higher than the originally expected IPO price of $ 32. The company’s share closed at $ 37.56 per share on the first tradingag.
The larger trend
Hinge announced his Plans to become public In 2022, a year after the collection of $ 300 million in series D financing and $ 400 million in a series E round.
The company Submitted in March for an IPO at the US Securities and Exchange Commission (SEC).
At the time of his IPO -InvestionThe company said it had more than 50 partners at the end of 2024, with a majority of its customers who have been contracted by large national or regional health plans and other partners who are large national PPEs.
The company has announced countless partnerships over the past two years, including one Extensive partnership with virtual healthcare company Teladoc, a collaboration with Amazon Health Services, a partnership with the virtual care specialist Midi Health for Women and a collaboration with the organization of employees and the government organization Sun Life.
#Hinge #health #public #collect #million #IPO